Keyphrases
Interleukin-2
100%
Clinical Trials
100%
Recombinant interleukin-2
100%
Activated Cells
100%
Adoptive Immunotherapy
100%
Patients with Cancer
100%
High Dose
66%
Cancer Patients
33%
Melanoma
33%
Neoadjuvant Setting
33%
Lymphokine-activated Killer Cells
33%
Pulmonary Metastasis
33%
Remission
33%
Jurkat
33%
Hepatic Metastasis
33%
Immunological Effects
33%
Safety Impact
33%
Toxicity Effects
33%
Transplanted Tumor
33%
Safety Toxicity
33%
Sequential Study
33%
Metastasis Model
33%
Conventional Cancer Treatment
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Clinical Trial
100%
Immunotherapy
100%
Interleukin 2
100%
Recombinant Interleukin 2
75%
Mouse
50%
Neoplasm
25%
Melanoma
25%
Remission
25%
Lung Metastasis
25%
Lymphokine
25%
Liver Metastasis
25%
Nursing and Health Professions
Interleukin 2
100%
Recombinant Interleukin 2
100%
Adoptive Immunotherapy
100%
Drug Megadose
66%
Neoplasm
33%
Remission
33%
Malignant Neoplasm
33%
Melanoma
33%
Cancer Therapy
33%
Lymphokine
33%
Immunotherapy
33%
Liver Metastasis
33%
Lung Metastasis
33%
Immunology and Microbiology
Interleukin 2
100%
Recombinant Interleukin 2
100%
Adoptive Immunotherapy
100%
Mouse
66%
Drug Megadose
66%
Immunotherapy
33%
Lymphokine Activated Killer Cell
33%
Veterinary Science and Veterinary Medicine